Author:
Klose K., ,Kreimeier S.,Tangermann U.,Aumann I.,Damm K.
Publisher
Springer Science and Business Media LLC
Reference65 articles.
1. Dirksen CD, Utens CM, Joore MA, van Barneveld TA, Boer B, Dreesens DH, et al. Integrating evidence on patient preferences in healthcare policy decisions: protocol of the patient-VIP study. IS. 2013;8:64. doi:
10.1186/1748-5908-8-64
.
2. Brettschneider C, Lühmann D, Raspe H. Der Stellenwert von Patient Reported Outcomes (PRO) im Kontext von Health Technology Assessment (HTA). Köln: DIMDI; 2011.
3. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for Industry. 2009.
http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf
. Accessed 14 May 2016.
4. Lohr KN, Zebrack BJ. Using patient-reported outcomes in clinical practice: challenges and opportunities. Qual Life Res. 2009;18:99–107. doi:
10.1007/s11136-008-9413-7
.
5. Valderas JM, Alonso J. Patient reported outcome measures: a model-based classification system for research and clinical practice. Qual Life Res. 2008;17:1125–35. doi:
10.1007/s11136-008-9396-4
.
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献